Next-Generation DNA Sequencing Platforms Market to More Than Double to $3.2 Billion by 2017
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 06/05/12 -- TriMarkPublications.com cites in its newly published " and PCR Markets" report that the next-generation platforms market will more than double, reaching $3.2 billion by 2017. For more information, visit: .
has a number of applications, including: full-genome resequencing, targeted discovery of mutations or polymorphisms, mapping of structural rearrangements, large-scale analysis of DNA methylation, RNA-Seq and ChIP-Seq. The U.S. and Europe exhibit the highest market penetration for , but other parts of the world are projected to see higher compound annual growth rates (CAGRs) of up to 13%. As platforms become increasingly affordable, the cost of sequencing a human genome will soon fall below the $1,000 price point.
The " and PCR Markets" report covers:
Polymerase Chain Reaction (PCR)
Nucleic Acid Amplification
Proteomics
Locked Nucleic Acid (LNA)
Capillary-Based Sequencers
Pyrosequencing
DNA Microarrays
RNA Isolation Kits
The " and PCR Markets" report examines companies manufacturing and PCR equipment and supplies in the world. Companies covered include: Abbott, Affymetrix, Agilent, AgriGen, Avesthagen Gengraine, BD, BGI Life, bioMerieux, Bioneer, Bio-Rad, BioServe, Caliper LifeSciences, Cepheid, Cogenics, CombiMatrix, Commonwealthnologies, Complete, Comprehensive Biomarker, CuraGen, Cytocell, DiaDexus, DNA LandMarks, DNAVision, DNASTAR, ELITech, Enigma, Enzo Biochem, Eppendorf, Eurofins Medigenomix, Exiqon, FASMAC, GE Healthcare, GeneticTechnologies, GeneWorks, Genia, Genisphere, Genovoxx, Gen-Probeorporated, Genset, GnuBIOorporated, GVK, Helicos, High Throughput, Hokkaido, Hy, Illumina, Inqabanical Industries, IntegenX, Integrated DNA, Intelligent Biosystems, Kreatech, LaserGen, LI-COR, Life, Lucigen, Luminex, Meridian, Microsynth, MilleGen SA, MWG, NanoString, NobleGen, Orchid Cellmark, Oxford Nanopore, Pacific, PamGene, PPD, PrimmBiotech, Promega, QIAGEN, RainDance, Research Biolabs, Roche, Rubicon, Saturn, SeeGene, Sequenom, Sequetech, SeqWright, Shanghai Sangon, Shimadzu, Siemens, SolGent, Stratos, TATAA Biocenter, Thermo Fisher, Third Wave, Wellcome Trust Sanger, ZS Genetics and ZyGEM.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
About TriMarkPublications.com
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.06.2012 - 17:45 Uhr
Sprache: Deutsch
News-ID 153383
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Information Services
Diese Pressemitteilung wurde bisher 233 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Next-Generation DNA Sequencing Platforms Market to More Than Double to $3.2 Billion by 2017"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
